PubMed · 2012 · 48 citations · 35 references
MedicineOncologyPharmacologyMetastasisRadiobiologyRadionuclide TherapyAlpha-particle TherapyBone MetastasisRadiation TherapyRadiopharmaceutical TherapyRadiopharmaceuticalsTargeted Radionuclide TherapyAdvanced Prostate Cancer TherapyBone Metastases ManagementBone Metastasis TherapyCastration-resistant Prostate Cancer TherapyMetastatic Castration-resistant Prostate CancerPalliative Radionuclide TherapyRadium TherapyTargeted Radiopharmaceutical Therapy
Approximately 85% to 90% of men with castration-resistant prostate cancer (CRPC) have radiological evidence of bone metastases. To date, however, therapies to manage bone metastases have been primarily palliative. Among CRPC patients with bone metastases, there is a significant unmet need for active antitumor treatment options that are highly efficacious and have a favorable safety profile. This article will present current information about alpha-pharmaceuticals, a new class of targeted cancer therapy for the treatment of patients with CRPC and bone metastases. It will review preclinical and clinical studies of the experimental radiopharmaceutical radium-223 chloride (Alpharadin), a first-in-class, highly targeted and well-tolerated alpha-pharmaceutical under development to improve survival in patients with bone metastases from advanced prostate cancer. Alpharadin kills cancer cells via alpha radiation from the decay of radium-223, a calcium mimetic that naturally self-targets to bone metastases. The mechanism of action of Alpharadin and specifics of administration, radiation protection, and patient management will be discussed.
35
Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text
Estimates of the cancer incidence and mortality in Europe in 2006
Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology · 2007 · 4K citations · Full text
G. David Roodman · New England Journal of Medicine · 2004 · 2.7K citations
Medicine, Oncology, Bone Metabolism +12